These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 10499910)
21. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding. Quinlan DJ; Eikelboom JW; Weitz JI Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012 [No Abstract] [Full Text] [Related]
22. Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on reversal agents. Di Fusco SA; Lucà F; Benvenuto M; Iorio A; Fiscella D; D'Ascenzo F; Madeo A; Colivicchi F; Di Lenarda A; Gulizia MM Int J Cardiol; 2018 Oct; 268():75-79. PubMed ID: 29843897 [TBL] [Abstract][Full Text] [Related]
23. Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence? Dickneite G; Hoffman M Thromb Haemost; 2014 Feb; 111(2):189-98. PubMed ID: 24136202 [TBL] [Abstract][Full Text] [Related]
25. Management of bleeding with oral anticoagulants in patients with atrial fibrillation. Bosch J; Eikelboom JW Hamostaseologie; 2015; 35(4):351-7. PubMed ID: 26013362 [TBL] [Abstract][Full Text] [Related]
26. Indications for prothrombin complex concentrates in massive transfusions. Blauhut B Thromb Res; 1999 Aug; 95(4 Suppl 1):S63-9. PubMed ID: 10499911 [TBL] [Abstract][Full Text] [Related]
27. Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal. Jones CA; Ducis K; Petrozzino J; Clark E; Fung MK; Peters C; Sarkar IN; Krol E; Pochal B; Boutrus A; Weimersheimer P; Freeman K Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):135-9. PubMed ID: 26211539 [TBL] [Abstract][Full Text] [Related]
28. Prothrombin complex concentrate for vitamin K antagonist reversal in acute bleeding settings: efficacy and safety. Ostermann H; von Heymann C Expert Rev Hematol; 2019 Jul; 12(7):525-540. PubMed ID: 31159607 [No Abstract] [Full Text] [Related]
29. Safety and effectiveness of Factor Eight Inhibitor Bypassing Activity for direct oral anticoagulant-related hemorrhage reversal. Engelbart JM; Zepeski A; Galet C; Policeni B; Skeete DA; Faine BA Am J Emerg Med; 2019 Feb; 37(2):214-219. PubMed ID: 29802004 [TBL] [Abstract][Full Text] [Related]
30. [EMERGENCY TREATMENT OF BLEEDING IN PATIENTS TAKING WARFARIN]. Prasolov NV; Shulutko EM; Bulanov AY; Yatskov KV; Shcherbakov OV Anesteziol Reanimatol; 2015; 60(2):72-6. PubMed ID: 26148369 [TBL] [Abstract][Full Text] [Related]
31. Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. Imberti D; Barillari G; Biasioli C; Bianchi M; Contino L; Duce R; D'Incà M; Gnani MC; Mari E; Ageno W Blood Transfus; 2011 Apr; 9(2):148-55. PubMed ID: 21251465 [TBL] [Abstract][Full Text] [Related]
32. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding. Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715 [TBL] [Abstract][Full Text] [Related]
33. Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature. Bershad EM; Suarez JI Neurocrit Care; 2010 Jun; 12(3):403-13. PubMed ID: 19967567 [TBL] [Abstract][Full Text] [Related]
34. Reversing the anticoagulation effects of dabigatran. Dager WE; Banares L Hosp Pract (1995); 2017 Apr; 45(2):29-38. PubMed ID: 28335637 [TBL] [Abstract][Full Text] [Related]
36. Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding. Imberti D; Magnacavallo A; Dentali F; Condoleo E; Gallerani M; Benedetti R; Ageno W J Thromb Thrombolysis; 2013 Jul; 36(1):102-8. PubMed ID: 23054464 [TBL] [Abstract][Full Text] [Related]
37. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa. Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317 [TBL] [Abstract][Full Text] [Related]
38. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation. Sin JH; Berger K; Lesch CA J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767 [TBL] [Abstract][Full Text] [Related]
39. Treatment With Prothrombin Complex Concentrate to Enable Emergency Lumbar Puncture in Patients Receiving Vitamin K Antagonists. Laible M; Beynon C; Sander P; Purrucker J; Müller OJ; Möhlenbruch M; Ringleb PA; Rizos T Ann Emerg Med; 2016 Sep; 68(3):340-4. PubMed ID: 27085368 [TBL] [Abstract][Full Text] [Related]
40. Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Ovesen C; Purrucker J; Gluud C; Jakobsen JC; Christensen H; Steiner T Syst Rev; 2018 Oct; 7(1):169. PubMed ID: 30342540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]